Recent Press Releases

Pacira Pharmaceuticals Enters into Strategic Co-Production Partnership with Patheon to Create Additional EXPAREL Manufacturing Capacity

PARSIPPANY, N.J.-- Pacira Pharmaceuticals, Inc.(NASDAQ:PCRX) today announced entering into a strategic co-production partnership with Patheon, the pharmaceutical services business owned by DPx...

DKSH extends collaboration with Bristol-Myers Squibb

Bangkok, Thailand – DKSH Business Unit Healthcare, the leading partner for healthcare companies seeking to grow their business in Asia, has extended the relationship started in 2010 with...

PAREXEL Appoints Peter Steiger, Ph.D., As Vice President Of Medical Imaging In Its Technology Subsidiary

BOSTON, April 14, 2014 -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced the appointment of Peter Steiger, Ph.D., to the newly created...

Study: Merit Increase Budgets on the Rise in the Global CRO Industry

A recent study conducted by HR+Survey Solutions reveals that merit increase budgets are on the rise in the Global CRO Industry. The study found that while the highest reported salary...

Karyopharm Therapeutics Inc. Enters into Preferred Provider Agreement with Clinipace Worldwide

MORRISVILLE, N.C.--Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today thatKaryopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company...

THERAMetrics and Pierrel Research International AG (PRINT) Announce a Cluster of Clinical Awards from medac GmbH

Stans, Switzerland, April 8, 2014 - THERAMetrics Holding AG (the "Company" - SIX: TMX) proudly announces that its fully-owned Pierrel Research International AG (PRINT) has been selected by...

PAREXEL Strengthens Executive Leadership With Appointments Of Roland Andersson, Ph.D. And Thomas Senderovitz, M.D. As Senior Vice Presidents Of Clinical Research Services

BOSTON -- PAREXEL International PRXL -2.05% , a leading global biopharmaceutical services organization, today announced Dr. Roland Andersson, Ph.D., and Dr. Thomas Senderovitz, M.D., as Senior Vice...

Charles River Laboratories Completes the Acquisition of the CRO Services Division of Galapagos NV

WILMINGTON, Mass.--()--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of the CRO services division...

Evotec and Convergence form integrated pain alliance

Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that it has entered into a research alliance with Panion Ltd, a subsidiary of Convergence...

Evotec and Debiopharm Group™ to Collaborate on Development of New Treatment for Cancer

LAUSANNE, Switzerland and HAMBURG, Germany -- Innovative partnership based on Evotec's Target X projects Evotec and Debiopharm to share discovery and development efforts Evotec AG...

AMRI Completes Acquisition of Cedarburg Pharmaceuticals, Inc.

ALBANY, N.Y. -- AMRI (NASDAQ: AMRI) today announced that it has completed the previously announced acquisition of Cedarburg Pharmaceuticals, Inc. Cedarburg, whose capabilities both augment and...

Particle Sciences and Actavis Enter into Joint Development Agreement

BETHLEHEM, Pa. -- Particle Sciences, a drug delivery Contract Development and Manufacturing Organization (CDMO), today announced that they have entered into an exclusive agreement with Actavis plc...

WuXi PharmaTech Corporate Venture Fund Invests in TruTag Security Platform for Drug Safety

SHANGHAI and HONOLULU -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States,...

Nexstim Selects Clinipace Worldwide to Manage Clinical Trial

MORRISVILLE, N.C.--Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today thatNexstim, a leader in navigated stimulation of the brain, has selected the company...

Strategic Partnerships Perceived As Most Effective Biopharmaceutical Outsourcing Model In Meeting Key Sponsor Needs, PAREXEL Report Reveals

BOSTON, March 31, 2014 -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today released Strategic Partnerships 2014: Driving Biopharmaceutical...

Catalent Increases Stake In Redwood Bioscience

Somerset, NJ – Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today...

BioClinica Inks $30 Million in eClinical Contracts with Two Top 10 Pharma Companies

NEWTOWN, Pa., March 26, 2014 /PRNewswire/ -- BioClinica®, Inc., a leading provider of specialized outsourced clinical trial services, today announced that it recently penned $30 million in...

Rho One of Five U.S. Companies Selected by HHS for Clinical Studies Network

CRO chosen to facilitate Medical Countermeasure (MCM) product development Chapel Hill, NC – March 26, 2014 - Rho, a contract research organization (CRO) focused on bringing new products to...

NephroGenex Announces Research Collaborations for Pivotal Studies of Pyridorin(TM) in Diabetic Nephropathy

RESEARCH TRIANGLE PARK, -- NephroGenex, Inc., a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced collaborations with two leading research...

BioDelivery Sciences Announces Commercialization Agreement with Quintiles to Support the Launch of BUNAVAIL in the U.S.

RALEIGH, N.C., March 27, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has entered into an agreement with Quintiles to provide a range of services to...